| 000 | 01544 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518051025.0 | ||
| 264 | 0 | _c20200318 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1473-2300 | ||
| 024 | 7 |
_a10.1177/0300060519859143 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHuang, He-Ming | |
| 245 | 0 | 0 |
_aReducing catheter-associated complications using 4% sodium citrate versus sodium heparin as a catheter lock solution. _h[electronic resource] |
| 260 |
_bThe Journal of international medical research _cSep 2019 |
||
| 300 |
_a4204-4214 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aBlood Coagulation |
| 650 | 0 | 4 |
_aCatheter-Related Infections _xetiology |
| 650 | 0 | 4 |
_aCentral Venous Catheters _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeparin _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aSodium Citrate _xpharmacology |
| 700 | 1 | _aJiang, Xin | |
| 700 | 1 | _aMeng, Ling-Bing | |
| 700 | 1 | _aDi, Chen-Yi | |
| 700 | 1 | _aGuo, Peng | |
| 700 | 1 | _aQiu, Yong | |
| 700 | 1 | _aDai, Ya-Lun | |
| 700 | 1 | _aLv, Xian-Qiang | |
| 700 | 1 | _aShi, Chang-Jin | |
| 773 | 0 |
_tThe Journal of international medical research _gvol. 47 _gno. 9 _gp. 4204-4214 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0300060519859143 _zAvailable from publisher's website |
| 999 |
_c29900445 _d29900445 |
||